209 related articles for article (PubMed ID: 27133297)
1. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.
Wang LJ; Li J; Hao FR; Yuan Y; Li JY; Lu W; Zhou TY
Acta Pharmacol Sin; 2016 Jun; 37(6):845-56. PubMed ID: 27133297
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase.
Gong H; Jarzynka MJ; Cole TJ; Lee JH; Wada T; Zhang B; Gao J; Song WC; DeFranco DB; Cheng SY; Xie W
Cancer Res; 2008 Sep; 68(18):7386-93. PubMed ID: 18794126
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral estrogen sulfotransferase induction contributes to the anti-breast cancer effects of the dithiocarbamate derivative TM208.
Ji XW; Chen GP; Song Y; Hua M; Wang LJ; Li L; Yuan Y; Wang SY; Zhou TY; Lu W
Acta Pharmacol Sin; 2015 Oct; 36(10):1246-55. PubMed ID: 25937633
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma.
Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H
Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664
[TBL] [Abstract][Full Text] [Related]
5. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
[TBL] [Abstract][Full Text] [Related]
7. ER2, a novel human anti-EGFR monoclonal antibody inhibit tumor activity in non-small cell lung cancer models.
Kang HN; Kim SH; Yun MR; Kim HR; Lim SM; Kim MS; Hong KW; Kim SM; Kim H; Pyo KH; Park HJ; Han JY; Youn HA; Chang KH; Cho BC
Lung Cancer; 2016 May; 95():57-64. PubMed ID: 27040853
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.
Yao Y; Yao QY; Xue JS; Tian XY; An QM; Cui LX; Xu C; Su H; Yang L; Feng YY; Hao CY; Zhou TY
Toxicol Appl Pharmacol; 2020 Aug; 401():115118. PubMed ID: 32619553
[TBL] [Abstract][Full Text] [Related]
9. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
Stabile LP; Lyker JS; Gubish CT; Zhang W; Grandis JR; Siegfried JM
Cancer Res; 2005 Feb; 65(4):1459-70. PubMed ID: 15735034
[TBL] [Abstract][Full Text] [Related]
10. Sanguinarine exhibits antitumor activity via up-regulation of Fas-associated factor 1 in non-small cell lung cancer.
Wei G; Xu Y; Peng T; Yan J; Wang Z; Sun Z
J Biochem Mol Toxicol; 2017 Aug; 31(8):. PubMed ID: 28296008
[TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
Lee I; Kalota A; Gewirtz AM; Shogen K
Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone alleviates pemetrexed-induced senescence in Non-Small-Cell Lung Cancer.
Ge H; Ke J; Xu N; Li H; Gong J; Li X; Song Y; Zhu H; Bai C
Food Chem Toxicol; 2018 Sep; 119():86-97. PubMed ID: 29753869
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of acriflavine in lung adenocarcinoma cell line A549.
Lee CJ; Yue CH; Lin YJ; Lin YY; Kao SH; Liu JY; Chen YH
Anticancer Res; 2014 Nov; 34(11):6467-72. PubMed ID: 25368247
[TBL] [Abstract][Full Text] [Related]
14. Dried leaf Artemisia annua efficacy against non-small cell lung cancer.
Rassias DJ; Weathers PJ
Phytomedicine; 2019 Jan; 52():247-253. PubMed ID: 30599905
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets.
Kausar H; Munagala R; Bansal SS; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 May; 332(1):35-45. PubMed ID: 23340170
[TBL] [Abstract][Full Text] [Related]
16. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft.
Kong M; Fan J; Dong A; Cheng H; Xu R
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.
Li J; Yao QY; Xue JS; Wang LJ; Yuan Y; Tian XY; Su H; Wang SY; Chen WJ; Lu W; Zhou TY
Acta Pharmacol Sin; 2017 Sep; 38(9):1282-1296. PubMed ID: 28649130
[TBL] [Abstract][Full Text] [Related]
18. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF
Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
